Freshfields advised Merz Therapeutics on its $185 million acquisition of Acorda Therapeutics. Merz Therapeutics, a renowned entity in the neurotoxins sector, has entered into an agreement...
Merz Therapeutics’ $185m Acquisition of Acorda Therapeutics
Merz Therapeutics’ License And Collaboration Agreement With Vensica
Hogan Lovells and Gross GKH advised Merz Therapeutics on the deal. Merz Therapeutics, a business of Merz Pharmaceuticals GmbH and part of the Merz Group, and...